The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

被引：0
|
作者：
Anaïs Chauvin
Chang-Shu Wang
Sameh Geha
Perrine Garde-Granger
Alex-Ane Mathieu
Vincent Lacasse
François-Michel Boisvert
机构：
[1] Université de Sherbrooke,Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences
[2] Université de Sherbrooke,Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences
[3] Université de Sherbrooke,Department of Pathology, Faculty of Medicine and Health Sciences
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Rectal cancer; Resistance to neoadjuvant radio-chemotherapy; 5-Fluorouracil; Proteomics; Mass spectrometry; Predictive biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
    Chauvin, Anais
    Wang, Chang-Shu
    Geha, Sameh
    Garde-Granger, Perrine
    Mathieu, Alex-Ane
    Lacasse, Vincent
    Boisvert, Francois-Michel
    CLINICAL PROTEOMICS, 2018, 15
  • [2] Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
    Wang, Jianan
    Liu, Jiayu
    Wang, Jinyang
    Wang, Shijian
    Li, Feifei
    Li, Ruibing
    Liu, Peng
    Li, Mianyang
    Wang, Chengbin
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [3] Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
    Jianan Wang
    Jiayu Liu
    Jinyang Wang
    Shijian Wang
    Feifei Li
    Ruibing Li
    Peng Liu
    Mianyang Li
    Chengbin Wang
    Cancer Cell International, 22
  • [4] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    G Klautke
    P Feyerherd
    K Ludwig
    F Prall
    T Foitzik
    R Fietkau
    British Journal of Cancer, 2005, 92 : 1215 - 1220
  • [5] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    Klautke, G
    Feyerherd, P
    Ludwig, K
    Prall, F
    Foitzik, T
    Fietkau, R
    BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1215 - 1220
  • [6] Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer A meta-analysis
    Zhu, Jinfeng
    Zeng, Wei
    Ge, Lei
    Yang, Xinhui
    Wang, Qisan
    Wang, Haijiang
    MEDICINE, 2019, 98 (17)
  • [7] Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer
    Baur, M.
    Horvath, M.
    Stattner, S.
    Schratter-Sehn, A.
    Horvath, B.
    Sellner, F.
    Hudec, M.
    Klimpfinger, M.
    Dittrich, C.
    Karner, J.
    ONCOLOGY LETTERS, 2010, 1 (01) : 189 - 194
  • [8] Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer
    Soo Jung Lee
    Byung Woog Kang
    Yee Soo Chae
    Hye Jin Kim
    Su Yeon Park
    Jun Seok Park
    Gyu Seog Choi
    Jong Gwang Kim
    Annals of Surgical Oncology, 2016, 23 : 894 - 899
  • [9] Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
    Kim, Yeon-Joo
    Lee, Woo Jin
    Woo, Sang Myung
    Kim, Tae Hyun
    Han, Sung-Sik
    Kim, Bo Hyun
    Moon, Sung Ho
    Kim, Sang Soo
    Koh, Young Hwan
    Park, Sang-Jae
    Kim, Joo-Young
    Kim, Dae Yong
    Park, Joong-Won
    RADIATION ONCOLOGY, 2013, 8
  • [10] Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
    Hanyang Wang
    Dengbo Ji
    Huifang Tian
    Zhaoya Gao
    Can Song
    Jinying Jia
    Xinxin Cui
    Lijun Zhong
    Jing Shen
    Jin Gu
    BMC Cancer, 22
12345